These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35012366)

  • 1. The role of nanomedicine in COVID-19 therapeutics.
    Sharma S
    Nanomedicine (Lond); 2022 Feb; 17(3):133-136. PubMed ID: 35012366
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanomedicine to deliver biological macromolecules for treating COVID-19.
    Wilson B; Mukundan Geetha K
    Vaccine; 2022 Jun; 40(29):3931-3941. PubMed ID: 35660038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology versus coronavirus.
    Nat Nanotechnol; 2020 Aug; 15(8):617. PubMed ID: 32764720
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
    Milane L; Amiji M
    Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special Focus Issue - Applications of nanotechnology against COVID-19: a special focus issue by
    Bough A
    Nanomedicine (Lond); 2021 Jun; 16(14):1177-1178. PubMed ID: 34044606
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints.
    Rai M; Bonde S; Yadav A; Plekhanova Y; Reshetilov A; Gupta I; Golińska P; Pandit R; Ingle AP
    Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1299-1308. PubMed ID: 33164589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology and COVID-19 Convergence: Toward New Planetary Health Interventions Against the Pandemic.
    Sahoo P; Dey J; Mahapatra SR; Ghosh A; Jaiswal A; Padhi S; Prabhuswamimath SC; Misra N; Suar M
    OMICS; 2022 Sep; 26(9):473-488. PubMed ID: 36040392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes.
    Al-Hatamleh MAI; Hatmal MM; Alshaer W; Rahman ENSEA; Mohd-Zahid MH; Alhaj-Qasem DM; Yean CY; Alias IZ; Jaafar J; Ferji K; Six JL; Uskoković V; Yabu H; Mohamud R
    Eur J Pharmacol; 2021 Apr; 896():173930. PubMed ID: 33545157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy.
    Mirtaleb MS; Mirtaleb AH; Nosrati H; Heshmatnia J; Falak R; Zolfaghari Emameh R
    Biomed Pharmacother; 2021 Jun; 138():111518. PubMed ID: 33774315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2.
    Tammam SN; El Safy S; Ramadan S; Arjune S; Krakor E; Mathur S
    J Control Release; 2021 Sep; 337():258-284. PubMed ID: 34293319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19.
    Rahman MM; Ahmed M; Islam MT; Khan MR; Sultana S; Maeesa SK; Hasan S; Hossain MA; Ferdous KS; Mathew B; Rauf A; Uddin MS
    Curr Pharm Des; 2022; 28(12):948-968. PubMed ID: 34218774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research and Patents on Coronavirus and COVID-19: A Review.
    Aranda P; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Darder M; Del Real G; Ruiz-Hitzky E
    Recent Pat Nanotechnol; 2020; 14(4):328-350. PubMed ID: 33087037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights from nanomedicine into chloroquine efficacy against COVID-19.
    Hu TY; Frieman M; Wolfram J
    Nat Nanotechnol; 2020 Apr; 15(4):247-249. PubMed ID: 32203437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccines and nanomedicine.
    Shapiro RS
    Int J Dermatol; 2021 Sep; 60(9):1047-1052. PubMed ID: 34089534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan and its derivatives as polymeric anti-viral therapeutics and potential anti-SARS-CoV-2 nanomedicine.
    Tan RSL; Hassandarvish P; Chee CF; Chan LW; Wong TW
    Carbohydr Polym; 2022 Aug; 290():119500. PubMed ID: 35550778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology Responses to COVID-19.
    Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P
    Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis.
    Alphandéry E
    Bioconjug Chem; 2020 Aug; 31(8):1873-1882. PubMed ID: 32639742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections.
    Loo CY; Lee WH; Zhou QT
    Pharm Res; 2023 May; 40(5):1015-1036. PubMed ID: 37186073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
    Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG
    ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations.
    Rai M; Bonde S; Yadav A; Bhowmik A; Rathod S; Ingle P; Gade A
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.